Cleveland Clinic researcher Vincent Tuohy first made waves back in 2010 when he published a promising study in Nature Medicine about a breast cancer vaccine he’d been developing. In that study, none of the cancer-prone mice injected with a single dose of the vaccine developed breast cancer, but all of the mice who didn’t get […]
Cleveland Clinic is seeking funding for human trials of a vaccine that could prevent the formation of breast cancer. Clinic immunologist Vincent Tuohy made a splash about two years ago, when his research on the vaccine was published in the journal Nature Medicine. The research showed that the vaccine prevented breast cancer in 100 percent […]
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
A vaccine to prevent breast cancer being developed by Cleveland Clinic researchers has shown “overwhelmingly favorable results” in animals and could be on its way to conquering the disease that kills more than 40,000 American women each year. Researchers led by Vincent Tuohy, an immunologist at the Clinic’s Lerner Research Institute, have found that a […]
Innovation in medical devices. Innovation in vaccines. Even innovation in regulating drug development -- MedCity News saw it all last week.
Vince Tuohy was surprised -- and grateful -- when the National Institutes of Health agreed to back development of his breast cancer vaccine after his first request. Tuohy's lab at the Cleveland Clinic's Lerner Research Institute is getting $1.3 million from the National Institutes of Health to continue to develop the vaccine.